Company CVAbout Bacil Pharma Ltd 
Bacil Pharma Ltd
Small Cap
Pharmaceuticals & Biotechnology
Incorporated as a private limited company in Maharashtra in May '87, Bacil Pharma (BPL) was converted into a public limited company in Oct.'90. The main business activity of the Company is Pharmaceutical. Bal Pharma is a fully integrated and leading Indian pharmaceutical company specialized in Prescription drugs, Branded Formulations, APIs, Generic & OTC products, Intravenous Infusions and Bulk Drugs. Domestic operations are spread across pan India.
Company Coordinates
Company Details
71 Laxmi Building, Sir P M Road Fort Mumbai Maharashtra : 400001
Registrar Details
Bigshare Services Pvt Ltd , E-2 , Ansa Industrial Estate, Saki Vihar Road, Saki Naka, Andheri (E), Mumbai
Capital StructureCapital Structure
Present Equity Capital
INR 5.89 Cr
Number of Shares
58.9 Cr
Face Value
INR 10.0
Date
Number
of Shares(Cr)
of Shares(Cr)
Equity
Capital (Rs Cr)
Capital (Rs Cr)
Shares Added
Face Value (Rs)
Reason
30-Mar-2007
58.9
5.89
-1110000
10
Forfeited Shares
30-Mar-2007
58.9
5.89
-1110000
10
Forfeited Shares
ShareholdingShareholding Snapshot
Shareholding Compare (%holding)
Majority shareholders
Non Institution
Pledged Promoter Holdings
None
Mutual Funds
Held by 0 Schemes
FIIs
Held by 0 FIIs
Promoter with highest holding
Sub Total A2 (0.08%)
Highest Public shareholder
Nikita Hiren Patel (19.44%)
Individual Investors Holdings
80.95%
Board of Directors
Management
Designation
Remuneration
Prakash Shah
Director
0
Ganpat Dhondu Salekar
Director
0
Shirish Shetye
Independent Director
0
Parul Dave
Independent Director
0
Suman Shah
Director
0
Bhavana Tak
Company Sec. & Compli. Officer
0
Raw MaterialsRaw Materials Dashboard
Raw Materials
Amount(Rs Cr)
% of RM Cost
No Data Available for Raw Material Segmentation
No Data Available
Finished Goods Finished Goods Dashboard
Finished Goods
Amount(Rs Cr)
% of Sales Turnover
Guar Dal - Traded
0.85
80.11%
Guar Split Broken - Traded
0.21
19.89%
Guar Dal - Traded
Guar Dal - Traded
Guar Split Broken - Traded
Guar Split Broken - Traded
Stock DNARevenue and Profits:
Net Sales:
(Quarterly Results - Sep 2025)
Net Profit:
0 Cr
Pharmaceuticals & Biotechnology
INR 60 Cr (Small Cap)
50.00
29
0.00%
-0.11
4.64%
2.32
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
